Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStill feeling hungry on Wegovy after your first few weeks is more common than most people expect. Semaglutide works by slowing how quickly food leaves your stomach and reducing appetite signals in the brain, but that effect builds gradually and isn't always linear. You're not doing anything wrong, and the treatment isn't necessarily failing. These are prescription-only medicines assessed individually by a clinician, so the specifics of your situation matter — but there are clear reasons why hunger can persist, and most of them are entirely normal at this stage.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've done two or three injections, you've been told appetite suppression is one of Wegovy's main effects, and yet you're still reaching for food at 10pm or thinking about lunch before you've finished breakfast. It feels like something's gone wrong. It usually hasn't.
Semaglutide builds in your system across the titration schedule. The 0.25mg starting dose is specifically designed to let your body adjust, with the therapeutic effect strengthening as doses increase over months. Most people notice meaningful appetite reduction somewhere between the 0.5mg and 1.7mg stages, not during that first pen. If you're still feeling hungry on Wegovy at this early stage, the answer usually involves both pharmacology and habit, and unpicking which is which takes a little time, and our guide on why you might still feel hungry on semaglutide walks through the most common reasons in detail. Give the medicine a fair runway before drawing conclusions.
Emotional hunger and habitual eating (reaching for food out of boredom, stress or routine) aren't governed by GLP-1 receptors. Wegovy suppresses physiological hunger, not psychological appetite. If your hunger is more automatic than physical, that pattern may not shift until you consciously address it alongside the medicine.
A question our prescribers hear most weeks is some version of: "I feel fine Monday to Wednesday, but by Sunday I'm ravenous again, is that normal?" Yes, almost always. Semaglutide has a half-life of roughly a week, which means its concentration in your bloodstream peaks shortly after your injection and tapers towards the end of the seven-day cycle. That dip can bring hunger back in the last day or two before your next dose.
This dose-end effect often becomes less noticeable as the maintenance dose is reached, partly because overall semaglutide levels are higher and the trough is less pronounced. In the meantime, knowing the pattern can help: some people find a slightly higher-protein lunch or a walk in the late afternoon takes the edge off that end-of-week window. You can read more about the overlapping reasons why hunger fluctuates on Wegovy throughout the week.
If the cycle is severe enough to feel distressing, that's worth raising with your prescriber at your next review. Timing of your injection day occasionally makes a practical difference to your week.
Wegovy reduces how much you want to eat. It doesn't automatically change what happens when you do eat. If your meals are carbohydrate-heavy and low in protein and fibre, you're likely to feel hungry again within two to three hours regardless of the medicine's effect on your appetite signals. Protein in particular takes longer to digest and has a direct satiety effect that works alongside semaglutide rather than in competition with it.
The eating approach that works best on Wegovy centres on protein-first meals, plenty of vegetables, adequate hydration and not skipping meals in an attempt to accelerate results, skipped meals often lead to stronger hunger signals later in the day. The NHS semaglutide guidance notes that Wegovy is prescribed alongside a reduced-calorie diet and increased activity; neither is optional.
Hunger at this stage can also be dehydration presenting as appetite. A full glass of water before sitting down to eat is a genuinely useful habit, not just filler advice. It won't suppress hunger the way semaglutide does, but distinguishing thirst from hunger is harder than most people expect, especially during the first few weeks of a new medicine.
Hunger that hasn't softened at all after three months on an appropriate dose is worth a proper clinical conversation. The NHS England guidance on weight management injections is clear that dose titration should be clinician-led and based on both tolerability and response. If hunger is persistent and your dose hasn't been reviewed recently, that may be the next step, but it's a decision made with a prescriber, not by adjusting your own schedule.
It's also worth being honest about what kind of hunger you're experiencing. Physical hunger (stomach growling, difficulty concentrating, light-headedness) responds to eating and to titration. Psychological hunger often doesn't, and addressing it may involve support beyond the medicine itself. Both are legitimate, and both are worth naming. The guide to persistent hunger throughout the treatment course goes into more depth on how these patterns tend to evolve.
If you're weighing up whether your current treatment is working as it should, our prescribers can review where you are in the process. Speak to our prescribers through a free consultation, every review at nume is handled by a GPhC-registered Independent Prescriber, the same day you submit your details. There are no hidden costs and no subscription tied to your next step. You can see a full overview of what the service covers on our Wegovy treatment page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.